Abstract: The present invention relates to peptidic selective GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, hyperglycemia, as well as the treatment of disorders associated with nausea and vomiting.
| # | Name | Date |
|---|---|---|
| 1 | 202417027694-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [03-04-2024(online)].pdf | 2024-04-03 |
| 2 | 202417027694-STATEMENT OF UNDERTAKING (FORM 3) [03-04-2024(online)].pdf | 2024-04-03 |
| 3 | 202417027694-Sequence Listing in txt [03-04-2024(online)].txt | 2024-04-03 |
| 4 | 202417027694-Sequence Listing in PDF [03-04-2024(online)].pdf | 2024-04-03 |
| 5 | 202417027694-REQUEST FOR EXAMINATION (FORM-18) [03-04-2024(online)].pdf | 2024-04-03 |
| 6 | 202417027694-FORM 18 [03-04-2024(online)].pdf | 2024-04-03 |
| 7 | 202417027694-FORM 1 [03-04-2024(online)].pdf | 2024-04-03 |
| 8 | 202417027694-DECLARATION OF INVENTORSHIP (FORM 5) [03-04-2024(online)].pdf | 2024-04-03 |
| 9 | 202417027694-COMPLETE SPECIFICATION [03-04-2024(online)].pdf | 2024-04-03 |
| 10 | 202417027694-FORM-26 [29-05-2024(online)].pdf | 2024-05-29 |
| 11 | 202417027694-Proof of Right [19-08-2024(online)].pdf | 2024-08-19 |
| 12 | 202417027694-FORM 3 [19-08-2024(online)].pdf | 2024-08-19 |